SCHEMBL5087386

SCHEMBL5087386

CCOC(=O)N(N)c1ccc(OCc2ccccc2C(F)(F)F)cc1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAOB P27338 4/20 0.58
MAOA P21397 1/20 0.58
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
SLC6A3 Q01959 1/20 0.46
KDM4E B2RXH2 2/20 0.44
ADAMTS4 O75173 1/20 0.44
MMP13 P45452 1/20 0.44
KMT2A Q03164 1/20 0.44
POLQ O75417 1/20 0.43
FFAR1 O14842 2/20 0.42
FFAR4 Q5NUL3 1/20 0.42
SPHK2 Q9NRA0 2/20 0.42
SPHK1 Q9NYA1 2/20 0.42
IDO1 P14902 2/20 0.42
ALOX5 P09917 1/20 0.41
ALOX5AP P20292 1/20 0.41
ALDH1A1 P00352 1/20 0.41
F2 P00734 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5089279 0.85 MAOB (0.55) MAOB
SCHEMBL5090942 0.84 MAOB (0.56) MAOBKDM4EMMP13KMT2AFFAR1
SCHEMBL5087373 0.84 OPRM1 (0.43) MAOBMAOASLC6A2SLC6A4SLC6A3
SCHEMBL5090322 0.79 L3MBTL1 (0.56) MAOBALOX5ALDH1A1
SCHEMBL5087387 0.79 MAOB (0.56) MAOBFFAR1
SCHEMBL5087189 0.78 MAOB (0.60) MAOBFFAR1FFAR4
SCHEMBL5096512 0.76 MAOB (0.57) MAOBFFAR1IDO1ALDH1A1
SCHEMBL5090818 0.75 MAOB (0.53) MAOBMAOAMMP13FFAR1ALDH1A1
SCHEMBL5090228 0.75 MAOB (0.38) MAOBKMT2AALDH1A1
SCHEMBL5090794 0.74 MAOB (0.49) MAOBADAMTS4MMP13ALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US claimed
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 MAOB 808/4885MAOA 1086/4885SLC6A2 265/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.